Autolus Therapeutics (AUTL) Shares Outstanding (2017 - 2026)

Autolus Therapeutics (AUTL) has 9 years of Shares Outstanding (Entity) data on file, last reported at $266.1 million in Q4 2025.

• Quarterly Shares Outstanding (Entity) changed 0.0% year-over-year to $266.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $266.1 million (changed 0.0% YoY) and the FY2025 annual result came in at $266.1 million, changed 0.0% from the prior year.
• Shares Outstanding (Entity) was little changed at $266.1 million in Q4 2025, from $266.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $266.1 million in Q3 2025 to a low of $62.4 million in Q1 2021.
• A 5-year average of $173.5 million and a median of $173.8 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) jumped 91.05% — and 2025, when it rose 0.0%.
• Tracing AUTL's Shares Outstanding (Entity) over 5 years: stood at $72.1 million in 2021, then soared by 31.78% to $95.0 million in 2022, then soared by 83.28% to $174.1 million in 2023, then surged by 52.86% to $266.1 million in 2024, then climbed by 0.0% to $266.1 million in 2025.
• The last three Shares Outstanding (Entity) figures came in at $266.1 million (Q4 2025), $266.1 million (Q3 2025), and $266.1 million (Q2 2025), per Business Quant data.